Plasma fatty acid levels may regulate the Zn2+-dependent activities of histidine-rich glycoprotein

Biochimie

Volumn 91, Issue 11-12, 2009, Pages 1518-1522

  Stewart, Alan J ^a   Blindauer, Claudia A ^b   Sadler, Peter J ^b  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Histidine rich glycoprotein; Human serum albumin; Thrombosis; Vascular biology; Zinc

Indexed keywords

ADAPTOR PROTEIN; FATTY ACID; HISTIDINE RICH GLYCOPROTEIN; HUMAN SERUM ALBUMIN; UNCLASSIFIED DRUG; ZINC ION;

ARTICLE; BLOOD CLOTTING; BLOOD VESSEL OCCLUSION; COMPLEX FORMATION; CRYSTAL STRUCTURE; DIABETES MELLITUS; FATTY ACID BLOOD LEVEL; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; IMMUNE SYSTEM; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; SOLID TUMOR; THROMBOSIS;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; FATTY ACIDS; HUMANS; PROTEINS; ZINC;

EID: 72649089897     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2009.08.002     Document Type: Article

References (57)

1. Jones A.L., Hulett M.D., and Parish C.R. Histidine-rich glycoprotein: a novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol. Cell Biol. 83 (2005) 106-118
2. Hulett M.D., and Parish C.R. Murine histidine-rich glycoprotein: cloning characterization and cellular origin. Immunol. Cell Biol. 78 (2000) 280-287
3. Saigo K., Shatsky M., Levitt L.J., and Leung L.L.K. Interaction of histidine-rich glycoprotein with human T lymphocytes. J. Biol. Chem. 264 (1989) 8249-8253
4. Corrigan J.J., Jeter M.A., Bruck D., and Feinberg W.M. Histidine-rich glycoprotein levels in children: the effect of age. Thromb. Res. 59 (1990) 681-686
5. Kuhli C., Scharrer I., Koch F., and Hattenbach L.O. Recurrent retinal vein occlusion in a patient with increased plasma levels of histidine-rich glycoprotein. Am. J. Opthamol. 135 (2003) 232-234
6. Engesser L., Kluft C., Briet E., and Brommer E.J. Familial elevation of plasma histidine-rich glycoprotein in a family with thrombophilia. Br. J. Haematol. 67 (1987) 355-358
7. Castaman G., Ruggeri M., Burei F., and Rodeghiero F. High levels of histidine-rich glycoprotein and thrombotic diathesis. Thromb. Res. 69 (1993) 297-305 Report of two unrelated families
8. Leung L.L. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J. Clin. Invest. 77 (1986) 1305-1311
9. Koide T., Foster D., Yoshitake S., and Davie E.W. Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotide sequence of its cDNA. Biochemistry 25 (1986) 2220-2225
10. Morgan W.T. Human serum histidine-rich glycoprotein. I. Interactions with heme, metal ions and organic ligands. Biochim. Biophys. Acta 535 (1978) 319-333
11. Borza D.B., and Morgan W.T. Histidine-proline-rich glycoprotein as a plasma pH sensor. Modulation of its interaction with glycosaminoglycans by pH and metals. J. Biol. Chem. 273 (1998) 5493-5499
12. 2+ chelation. J. Biol. Chem. 279 (2004) 30114-30122
13. Mori S., Shinohata R., Renbutsu M., Takahashi H.K., Fang Y.I., Yamaoka K., Okamoto M., Yamamoto I., and Nishibori M. Histidine-rich glycoprotein plus zinc reverses growth inhibition of vascular smooth muscle cells by heparin. Cell Tissue Res. 312 (2003) 353-359
14. Guan X., Juarez J.C., Qi X., Shipulina N.V., Shaw D.E., Morgan W.T., McCrae K.R., Mazar A.P., and Doñate F. Histidine-proline rich glycoprotein (HPRG) binds and transduces anti-angiogenic signals through cell surface tropomyosin on endothelial cells. Thromb. Haemost. 92 (2004) 403-412
15. Gorgani N.N., Parish C.R., and Altin J.G. Differential binding of histidine-rich glycoprotein (HRG) to human IgG subclasses and IgG molecules containing kappa and lambda light chains. J. Biol. Chem. 274 (1999) 29633-29640
16. Gorgani N.N., Parish C.R., Easterbrook Smith S.B., and Altin J.G. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes. Biochemistry 36 (1997) 6653-6662
17. Jones A.L., Hulett M.D., Altin J.G., Hogg P., and Parish C.R. Plasminogen is tethered with high affinity to the cell surface by the plasma protein, histidine-rice glycoprotein. J. Biol. Chem. 279 (2004) 38267-38276
18. Walz D.A., Bacon-Baguley T., Kendra-Franzak S., and DePoli P. Binding of thrombospondin to immobilized ligands: specific interaction with fibrinogen, plasminogen, histidine-rich glycoprotein, and fibronectin. Semin. Thromb. Hemost. 13 (1987) 317-325
19. Sarkar B. Metal-protein interactions in transport, accumulation, and excretion of metals. Biol. Trace Elem. Res. 21 (1989) 137-144
20. Guthans S.L., and Morgan W.T. The interaction of zinc, nickel and cadmium with serum albumin and histidine-rich glycoprotein assessed by equilibrium dialysis and immunoadsorbent chromatography. Arch. Biochem. Biophys. 218 (1982) 320-328
21. Sugio S., Kashima A., Mochizuki S., Noda M., and Kobayashi K. Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng. 12 (1999) 439-446
22. Masuoka J., Hegenauer J., Van Dyke B.R., and Saltman P. Intrinsic stoichiometric equilibrium constants for the binding of zinc(II) and copper(II) to the high affinity site of serum albumin. J. Biol. Chem. 268 (1993) 21533-21537
23. Blindauer C.A., Harvey I., Bunyan K.E., Stewart A.J., Sleep D., Harrison D.J., Berezenko S., and Sadler P.J. Structure, properties, and engineering of the major zinc binding site on human albumin. J. Biol. Chem. (2009) 10.1074/jbc.M109.003459
24. Failla M.L., van de Veerdonk M., Morgan W.T., and Smith Jr. J.C. Characterization of zinc-binding proteins of plasma in familial hyperzincemia. J. Lab. Clin. Med. 100 (1982) 943-952
25. Smith K.T., Failla M.L., and Cousins R.J. Identification of albumin as the plasma carrier for zinc absorption by perfused rat intestine. Biochem. J. 184 (1979) 627-633
26. Rowe D.J., and Bobilya D.J. Albumin facilitates zinc acquisition by endothelial cells. Proc. Soc. Exp. Biol. Med. 224 (2000) 178-186
27. Gálvez M., Moreno J.A., Elósegui L.M., and Escanero J.F. Zinc uptake by human erythrocytes with and without serum albumins in the medium. Biol. Trace Elem. Res. 84 (2001) 45-56
28. Tibaduiza E.C., and Bobilya D.J. Zinc transport across an endothelium includes vesicular cotransport with albumin. J. Cell. Physiol. 167 (1996) 539-547
29. Stewart A.J., Blindauer C.A., Berezenko S., Sleep D., and Sadler P.J. Interdomain zinc site on human albumin. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 3701-3706
30. Lu J., Stewart A.J., Sadler P.J., Pinheiro T.J.T., and Blindauer C.A. Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. Biochem. Soc. Trans. 36 (2008) 1317-1321
31. 113Cd-NMR study. Biochem. Cell Biol. 69 (1991) 809-820
32. 2+. Inorg. Chem. 35 (1996) 4490-4496
33. A.J. Stewart, Metal Binding and Redox Properties of Human Albumin, PhD thesis, University of Edinburgh, 2003.
34. Curry S., Mandelkow H., Brick P., and Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Biol. 5 (1998) 827-835
35. Bhattacharya A.A., Curry S., and Franks N.P. Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J. Biol. Chem. 275 (2000) 38731-38738
36. Bhattacharya A.A., Grüne T., and Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 303 (2000) 721-732
37. Petitpas I., Grüne T., Bhattacharya A.A., and Curry S. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J. Mol. Biol. 314 (2001) 955-960
38. He X.M., and Carter D.C. Atomic structure and chemistry of human serum albumin. Nature 358 (1992) 209-215
39. Peters Jr. T. All About Albumin: Biochemistry, Genetics, and Medical Applications (1996), Academic Press, New York
40. Jørgensen J.R., Fitch M.D., Mortensen P.B., and Fleming S.E. In vivo absorption of medium-chain fatty acids by the rat colon exceeds that of short-chain fatty acids. Gastroenterology 120 (2001) 1152-1161
41. Richieri G.V., Anel A., and Kleinfeld A.M. Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry 32 (1993) 7574-7580
42. Bartter F.C., Steinfeld J.L., Waldmann T., and Delea C.S. Metabolism of infused serum albumin in the hypoproteinemia of gastrointestinal protein loss and in analbuminemia. Trans. Assoc. Am. Physicians 74 (1961) 180-194
43. Burch D.J., and O'Neill A.M. Obesity and pregnancy. Obesity is a risk factor for thromboembolism. BMJ (2009) 10.1136/bmj.b388
44. Eichinger S., Hron G., Bialonczyk C., Hirschl M., Minar E., Wagner O., Heinze G., and Kyrle P.A. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch. Int. Med. 168 (2008) 1678-1683
45. Prandoni P., and Kahn S.R. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br. J. Haematol. 145 (2009) 286-295
46. Connolly G.C., and Khorana A.A. Risk stratification for cancer-associated venous thromboembolism. Best Pract. Res. Clin. Haematol. 22 (2009) 35-47
47. Lee A.Y. Treatment of venous thromboembolism in cancer patients. Best Pract. Res. Clin. Haematol. 22 (2009) 93-101
48. Koot B.G.P., Houwen R., Pot D.J., and Nauta J. Congenital analbuminaemia: biochemical and clinical implications. A case report and literature review. Eur. J. Pediatr. 163 (2004) 664-670
49. Shabanzadeh A.P.-., Shuaib A., Yang T., Salam A., and Wang C.X. Effect of zinc in ischemic brain injury in an embolic model of stroke in rats. Neurosci. Lett. 356 (2004) 69-71
50. Prost-Dvojakovic R.J., and Samama M. Clot-promoting and platelet-aggregating effects of fatty acids. Haemostasis 174 (1973) 73-84
51. Kerr J.W., MacAulay I., Pirrie R., and Bronte-Stewart B. Platelet-aggregation by phospholipids and free fatty acids. Lancet 1 (1965) 1296-1299
52. Knapp H.R. Dietary fatty acids in human thrombosis and hemostasis. Am. J. Clin. Nutr. 65 suppl (1997) l687S-1698S
53. Shigekiyo T., Ohshima T., Oka H., Tomonari A., Azuma H., and Saito S. Congenital histidine-rich glycoprotein deficiency. Thromb. Haemost. 70 (1993) 263-265
54. Souto J.C., Garí M., Falkon L., and Fortcuberta J. A new case of hereditary histidine-rich glycoprotein deficiency with familial thrombophilia. Thromb. Haemost. 75 (1997) 374-375
55. Shigekiyo T., Yoshida H., Kanagawa Y., Satoh K., Wakabayashi S., Matsumoto T., and Koide T. Histidine-rich glycoprotein (HRG) Tokushima 2: novel HRG deficiency, molecular and cellular characterization. Thromb. Haemost. 84 (2000) 675-679
56. Shigekiyo T., Kanazuka M., Azuma H., Ohshima T., Kusaka K., and Saito S. Congenital deficiency of histidine-rich glycoprotein: failure to identify abnormalities in routine laboratory assays of hemostatic function, immunologic function, and trace elements. J. Lab. Clin. Med. 125 (1995) 719-723
57. Tsuchida-Straeten N., Ensslen S., Schäfer C., Wöltje M., Denecke B., Moser M., Gräber S., Wakabayashi S., Koide T., and Jahnen-Dechent W. Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein. J. Thromb. Haemost. 3 (2005) 865-872